TP53 and malignant peripheral nerve sheath tumor: Undoubtably, this model oversimplifies the genetic progression of the cell towards malignancy and minimizes the contribution of mutations in other genes, such as TP53. However, given the high recurrence of PRC2 alterations, this review will focus on summarizing the current understanding of PRC2 loss in MPNST pathogenesis.